Additionally, tirzepetide (branded Mounjaro/Zepbound) is an emerging GLP-1 agonist with a dual mechanism of action that targets both the GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors
PlexusDx's Precision Peptide Genetic Test maps 14 metabolic pathways and analyzes 49 peptide-related genes to reveal your unique GLP-1 responsiveness profile
As a practice, we are here to provide support as you tackle this challenge
By stimulating glucose-dependent insulin secretion and reducing liver glucose production, tirzepatide addresses weight loss through broader biochemical mechanisms than single-pathway drugs
doi:10.1016/j.ajog.2015.07.001 39
Content & Media Disclaimer Some content on this website, including text, images, and other media, may be generated or enhanced using artificial intelligence technologies